TXG
10x Genomics, Inc. · Healthcare · Medical - Healthcare Information Services
Input momentum (manajer yang sebanding):
keluasan pemegang +7.1% ·
aliran saham +1.4% ·
posisi baru bersih +6.7%
· formula
Akumulasi luas: saham yang meningkat di lebih banyak pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q4 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 153.99K | $11.76M | n/a | n/a |
| Q2 2026 | 113 | +6 | 98.93M | $3.79B | +15 | −8 |
| Q1 2026 | 109 | +3 | 94.02M | $1.99B | +12 | −10 |
| Q4 2025 | 107 | +3 | 97.86M | $1.59B | +4 | n/a |
| Q3 2025 | 19 | -2 | 71.88M | $839.83M | n/a | −3 |
| Q2 2025 | 19 | +1 | 64.66M | $748.72M | +2 | −1 |
| Q1 2025 | 15 | 0 | 30.56M | $266.82M | +1 | −1 |
| Q4 2024 | 15 | +1 | 24.83M | $356.61M | +3 | −2 |
| Q3 2024 | 13 | 0 | 22.71M | $512.82M | +1 | −1 |
| Q2 2024 | 13 | n/a | 21.07M | $409.76M | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 11.94M | +11.1% | $171.52M | 1.4% | ▲ Add | 3 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 2.01M | -27.8% | $28.81M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 3 | Geode Capital Management ✦ (pasif) | 1.81M | -0.1% | $26.07M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 4 | T. Rowe Price ✦ | 1.78M | -29.2% | $25.58M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 5 | State Street Global Advisors ✦ (pasif) | 1.77M | n/a | $25.49M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Two Sigma Investments ✦ | 1.32M | +291.2% | $18.95M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 1.22M | Baru | $17.50M | 0.0% | New | 1 | SEC ↗ ×2 |
| 8 | Millennium Management ✦ | 991.16K | +7.9% | $14.23M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Capital World Investors ✦ | 793.30K | 0.0% | $11.39M | 0.0% | Held | 3 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 517.20K | -29.1% | $7.43M | 0.0% | ▼ Trim | 3 | SEC ↗ ×4 |
| 11 | Renaissance Technologies ✦ | 386.95K | Baru | $5.56M | 0.0% | New | 1 | SEC ↗ |
| 12 | PRIMECAP Management ✦ | 127.60K | -56.8% | $1.83M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Norges Bank ✦ (pasif) | 91.58K | +123.0% | $1.32M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Marshall Wace ✦ | 46.86K | -90.0% | $672,924 | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 15 | Gotham Asset Management ✦ | 18.39K | Baru | $264,066 | 0.0% | New | 1 | SEC ↗ |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| D. E. Shaw & Co. | $17.50M | 0.0% |
| Renaissance Technologies | $5.56M | 0.0% |
| Gotham Asset Management | $264,066 | 0.0% |
Telah keluar
| Point72 Asset Management | $27.78M | adalah 0.1% |
| Baillie Gifford | $911,736 | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 328 pemegang, 124.40M saham, $2.59B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer, Director · 1.00K lbr · $78,228
Director · 1.22K lbr · $100,542
Director · 2.27K lbr · $185,391
Director · 1.32K lbr · $107,082
Director · 614 lbr · $48,820
Director · 292 lbr · $22,833
Officer, Director · 2.80K lbr · $230,622
Officer, Director · 9.90K lbr · $810,071
Officer, Director · 9.30K lbr · $752,401
Officer, Director · 2.00K lbr · $159,239
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi